Together, We Transform 60 : Alpro Group Advance Early Thyroid Detection for Ageing Malaysians: news

Together, We Transform 60+: Alpro Group Advances Early Thyroid Detection for Ageing Malaysians

Alpro Group, in collaboration with science and technology company Merck Malaysia, has officially rolled out the “Together, We Transform 60+” nationwide healthcare campaign. The initiative aims to advance early thyroid disorder detection, improve senior healthcare screening, and promote healthy ageing across Malaysian communities.

Bridging the Thyroid Awareness Gap in Senior Health

Thyroid dysfunction, particularly hypothyroidism, often goes underdiagnosed among older adults. Common symptoms such as persistent fatigue, unexplained weight gain, muscle weakness, dry skin, and memory lapses are frequently dismissed as inevitable side effects of natural ageing.

The “Together, We Transform 60+” campaign addresses this diagnostic gap by educating senior citizens, caregivers, and families on distinguishing common ageing complaints from manageable endocrine disorders.

Community-Based Screening and Preventative Healthcare

By leveraging Alpro Pharmacy’s nationwide retail network, the campaign brings accessible screening tools and clinical consultation directly to local communities:

• Community-Led Risk Assessment: Pharmacists and healthcare professionals across Alpro outlets evaluate symptoms, identify at-risk seniors, and offer basic health screenings.

  Macau Business

• Timely Medical Referrals: Individuals exhibiting signs of thyroid hormone imbalances are connected with clinical physicians for comprehensive blood tests, such as Thyroid-Stimulating Hormone (TSH) evaluations.

• Public Education & Caregiver Support: Interactive educational materials clarify how metabolic health directly affects energy levels, cognitive performance, and long-term vitality in individuals aged 60 and older.

Fostering Preventative Care for Malaysia’s Ageing Population

As Malaysia transitions toward an ageing society, preventative health measures remain critical to reducing long-term strain on tertiary medical facilities. The collaborative partnership between Alpro Group and Merck establishes an accessible first line of defence, ensuring older Malaysians receive prompt diagnosis, intervention, and the medical care required for healthy, independent longevity.